E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/9/2016 in the Prospect News PIPE Daily.

Ekso Bionics Holdings prices $15 million public stock sale at $4.00

Cowen is the bookrunner; proceeds are expected to finance operations

By Devika Patel

Knoxville, Tenn., Aug. 9 – Ekso Bionics Holdings, Inc. said it priced a $15 million public offering of stock with a $2.25 million greenshoe. The offering was announced Monday.

The company will sell 3.75 million common shares at $4.00 per share. The price per share is a 35.69% discount to the Aug. 8 closing share price of $6.22.

Cowen and Co. is the bookrunner, and SunTrust Robinson Humphrey is the lead manager.

Settlement is expected Aug. 12.

Proceeds will be used for operations.

The Richmond, Calif., company develops and manufactures human bionic exoskeletons.

Issuer:Ekso Bionics Holdings, Inc.
Issue:Common stock
Amount:$15 million
Greenshoe:$2.25 million, or 562,500 shares
Shares:3.75 million
Price:$4.00
Warrants:No
Bookrunner:Cowen and Co.
Lead manager:SunTrust Robinson Humphrey
Co-manager:B. Riley & Co.
Announcement date:Aug. 8
Pricing date:Aug. 9
Settlement date:Aug. 12
Stock symbol:Nasdaq: EKSO
Stock price:$6.22 at close Aug. 8
Market capitalization:$102.21 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.